Combination angiotensin receptor blocker-neutral endopeptidase inhibitor provides additive blood pressure reduction over angiotensin receptor blocker alone

Journal of Clinical Hypertension

Volumn 12, Issue 10, 2010, Pages 809-812

  Bloch, Michael J ^a   Basile, Jan N ^b  

^a St Mary's Regional Med Center   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AHU 377; ALDOSTERONE; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATRIAL NATRIURETIC FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; ENKEPHALINASE INHIBITOR; LCZ 696; MEMBRANE METALLOENDOPEPTIDASE; OMAPATRILAT; PLACEBO; UNCLASSIFIED DRUG; VALSARTAN; VASOPEPTIDASE INHIBITOR;

ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE MONITORING; BLOOD TOXICITY; BODY WEIGHT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DRUG FATALITY; DRUG RECEPTOR BINDING; DRUG WITHDRAWAL; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; HEART PROTECTION; HUMAN; HYPERTENSION; MONOTHERAPY; NOTE; ORTHOSTATIC BLOOD PRESSURE; PRIORITY JOURNAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT;

AMINOBUTYRIC ACIDS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NEPRILYSIN; PYRIDINES; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES; THIAZEPINES;

EID: 77957316058     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2010.00358.x     Document Type: Note

References (0)